Antonella De Rosa

Royal Prince Alfred Hospital

Papers

1

Total Citations

2

H-Index

1

About

Dr. Antonella De Rosa is a surgical oncologist whose research focuses on optimizing surgical management for high-risk prostate cancer, with a particular emphasis on the role of extended pelvic lymph node dissection (ePLND). Her major contribution is the development and pilot testing of the NODE Trial, a prospective multicentre randomized trial designed to rigorously evaluate whether ePLND improves oncologic outcomes compared to standard approaches. As the lead author of the protocol for this pilot study (2021), Dr. De Rosa established critical feasibility data, demonstrating acceptable recruitment rates and setting the stage for a larger-scale definitive trial. While her most-cited work currently has 2 citations, its significance lies in its foundational role for a practice-changing study that addresses a longstanding debate in urologic oncology. Her work is notable for its methodological rigor in tackling a complex surgical question, and she is recognized for advancing evidence-based surgical decision-making in prostate cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Protocol for a Pilot Study of the NODE Trial, a Prospective Multicentre Randomised Trial of Extended Pelvic Lymph Node Dissection for High-Risk Prostate Cancer
2 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Royal Prince Alfred Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago